Evidence map›Paper›PMID 41992461›Full record

ReviewRecent patents on biotechnology2026

Unveiling the Modern Therapeutic Properties and Folk Medicinal Riches of

Diksha Sharma, Divya Jain, Deepika Bhatia

Abstract readReview
PubMed Publisher
In one paragraph

Review in Recent patents on biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Diksha SharmaUniversity Institute of Pharma Sciences, Chandigarh University, Mohali, Punjab, 140413, India.
Divya JainDepartment of Microbiology, School of Applied & Life Sciences, Uttaranchal University, Dehradun, Uttarakhand, 248007, India.
Deepika BhatiaUniversity Institute of Pharma Sciences, Chandigarh University, Mohali, Punjab, 140413, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rubia cordifolia (Manjishtha), a perennial herb of the Rubiaceae family, has been valued in traditional medicine for its diverse pharmacological properties. Predominantly cultivated in hilly regions, its roots have been historically used for their red pigment and therapeutic applications in Ayurveda. R. cordifolia has been traditionally employed for skin diseases, menstrual disorders, snake bites, herpes, eye diseases, haemorrhoids, and fractures. Modern research highlights its potent antioxidant, antimicrobial, and hepatoprotective properties, with evidence supporting its role in managing acne, inflammation, cancer, diabetes, Alzheimer's disease, and infectious diseases. Furthermore, its integration into various Ayurvedic formulations emphasizes its clinical significance. A comprehensive literature review highlights its bioactive compounds and their therapeutic relevance in modern medicine. The review aims to provide a comprehensive knowledge of the pharmacological impacts, the active components, and the medicinal applications of R. cordifolia. It uncovers new bioactive compounds, mechanisms of action, or novel formulations, patent protection becomes essential.

Indexed as

Plant ExtractsRubiaAnimalsAnti-Infective AgentsAntioxidantsHumansMedicine, AyurvedicMedicine, TraditionalPatents as TopicAnti-Infective AgentsAntioxidantsPlant Extractsbioactive compoundshepatoprotective propertiesmodern medicinepharmacological propertiesRubia cordifoliatherapeutic applications

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.